Keywords: phytomedics, eisai, enter, cancer, collaboration, privately-held, biotechnology

Phytomedics and Eisai enter cancer collaboration

Article | 25 February 2002

Privately-held US biotechnology firm Phytomedics Inc has entered into anagreement with Eisai Research Institute of Boston Inc (wholly-owned by Eisai ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in